These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31994640)

  • 1. Early diagnosis and treatment of Alzheimer's disease: new definitions and challenges.
    Pais M; Martinez L; Ribeiro O; Loureiro J; Fernandez R; Valiengo L; Canineu P; Stella F; Talib L; Radanovic M; Forlenza OV
    Braz J Psychiatry; 2020 Aug; 42(4):431-441. PubMed ID: 31994640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
    Dubois B; Hampel H; Feldman HH; Scheltens P; Aisen P; Andrieu S; Bakardjian H; Benali H; Bertram L; Blennow K; Broich K; Cavedo E; Crutch S; Dartigues JF; Duyckaerts C; Epelbaum S; Frisoni GB; Gauthier S; Genthon R; Gouw AA; Habert MO; Holtzman DM; Kivipelto M; Lista S; Molinuevo JL; O'Bryant SE; Rabinovici GD; Rowe C; Salloway S; Schneider LS; Sperling R; Teichmann M; Carrillo MC; Cummings J; Jack CR;
    Alzheimers Dement; 2016 Mar; 12(3):292-323. PubMed ID: 27012484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring.
    van Oostveen WM; de Lange ECM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges.
    Cano A; Turowski P; Ettcheto M; Duskey JT; Tosi G; Sánchez-López E; García ML; Camins A; Souto EB; Ruiz A; Marquié M; Boada M
    J Nanobiotechnology; 2021 Apr; 19(1):122. PubMed ID: 33926475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the path to 2025: understanding the Alzheimer's disease continuum.
    Aisen PS; Cummings J; Jack CR; Morris JC; Sperling R; Frölich L; Jones RW; Dowsett SA; Matthews BR; Raskin J; Scheltens P; Dubois B
    Alzheimers Res Ther; 2017 Aug; 9(1):60. PubMed ID: 28793924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Defining and disease-modifying therapy for the preclinical stages of Alzheimer's disease].
    Sakurai H; Hanyu H
    Nihon Rinsho; 2016 Mar; 74(3):438-41. PubMed ID: 27025083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toward Preclinical Trials for Alzheimer's Disease].
    Miyagawa T; Iwatsubo T
    Brain Nerve; 2017 Jul; 69(7):711-722. PubMed ID: 28739984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria.
    Dulewicz M; Kulczyńska-Przybik A; Mroczko P; Kornhuber J; Lewczuk P; Mroczko B
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
    Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
    Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward an early diagnosis and treatment of Alzheimer's disease.
    Nordberg A
    Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological markers for early detection and pharmacological treatment of Alzheimer's disease.
    Hampel H; Broich K; Hoessler Y; Pantel J
    Dialogues Clin Neurosci; 2009; 11(2):141-57. PubMed ID: 19585950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmonized diagnostic criteria for Alzheimer's disease: recommendations.
    Morris JC; Blennow K; Froelich L; Nordberg A; Soininen H; Waldemar G; Wahlund LO; Dubois B
    J Intern Med; 2014 Mar; 275(3):204-13. PubMed ID: 24605805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease.
    Villa C; Stoccoro A
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.
    Hampel H; Lista S
    J Nutr Health Aging; 2013 Jan; 17(1):54-63. PubMed ID: 23299381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in Alzheimer's disease.
    Galimberti D; Scarpini E
    J Neurol; 2012 Feb; 259(2):201-11. PubMed ID: 21706152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.